Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment

SIMPLE SUMMARY: Our findings indicated that the EGF-EGFR pathway was highly activated in very young patients with recurrent or metastatic NPC. High EGFR expression in patients with metastatic NPC resulted in poor clinical outcomes. To examine whether the EGFR pathway serves as a therapeutic target f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hsin-Pai, Huang, Chen-Yang, Lui, Kar-Wai, Chao, Yin-Kai, Yeh, Chun-Nan, Lee, Li-Yu, Huang, Yenlin, Lin, Tung-Liang, Kuo, Yung-Chia, Huang, Mei-Yuan, Lai, Yi-Ru, Yeh, Yuan-Ming, Fan, Hsien-Chi, Lin, An-Chi, Hsieh, Jason Chia-Hsun, Chang, Kai-Ping, Lin, Chien-Yu, Wang, Hung-Ming, Chang, Yu-Sun, Hsu, Cheng-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231497/
https://www.ncbi.nlm.nih.gov/pubmed/34204797
http://dx.doi.org/10.3390/cancers13122954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231497/
https://www.ncbi.nlm.nih.gov/pubmed/34204797
http://dx.doi.org/10.3390/cancers13122954

Ejemplares similares